A cerebrospinal fluid microRNA signature as biomarker for glioblastoma

被引:103
|
作者
Akers, Johnny C. [1 ]
Hua, Wei [2 ]
Li, Hongying [3 ]
Ramakrishnan, Valya [1 ]
Yang, Zixiao [2 ]
Quan, Kai [2 ]
Zhu, Wei [2 ]
Li, Jie [1 ]
Figueroa, Javier [1 ]
Hirshman, Brian R. [1 ]
Miller, Brittney [1 ]
Piccioni, David [4 ]
Ringel, Florian [5 ]
Komotar, Ricardo [6 ]
Messer, Karen [3 ]
Galasko, Douglas R. [7 ]
Hochberg, Fred [1 ]
Mao, Ying [7 ,8 ]
Carter, Bob S. [1 ]
Chen, Clark C. [1 ]
机构
[1] Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA
[2] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China
[3] UC San Diego Hlth Syst, Moores Canc Ctr, Biostat Dept, La Jolla, CA USA
[4] UC San Diego Hlth Syst, Moores Canc Ctr, Dept Neurosurg, La Jolla, CA USA
[5] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany
[6] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA
[7] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA
[8] Fudan Univ, Inst Brain Sci, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China
关键词
extracellular vesicle; CSF; liquid biopsy; EXOSOMES; BIOPSY; DIAGNOSIS; RESECTION; MIRNAS; LUMBAR; BRAIN; SET;
D O I
10.18632/oncotarget.18332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To develop a cerebrospinal fluid (CSF) miRNA diagnostic biomarker for glioblastoma. Experimental Design: Glioblastoma tissue and matched CSF from the same patient (obtained prior to tumor manipulation) were profiled by TaqMan OpenArray (R) Human MicroRNA Panel. CSF miRNA profiles from glioblastoma patients and controls were created from three discovery cohorts and confirmed in two validation cohorts. Results: miRNA profiles from clinical CSF correlated with those found in glioblastoma tissues. Comparison of CSF miRNA profiles between glioblastoma patients and non-brain tumor patients yielded a tumor "signature" consisting of nine miRNAs. The " signature" correlated with glioblastoma tumor volume (p=0.008). When prospectively applied to cisternal CSF, the sensitivity and specificity of the 'signature' for glioblastoma detection were 67% and 80%, respectively. For lumbar CSF, the sensitivity and specificity of the signature were 28% and 95%, respectively. Comparable results were obtained from analyses of CSF extracellular vesicles (EVs) and crude CSF. Conclusion: We report a CSF miRNA signature as a "liquid biopsy" diagnostic platform for glioblastoma.
引用
收藏
页码:68769 / 68779
页数:11
相关论文
共 50 条
  • [21] Challenges in cerebrospinal fluid shunting in patients with glioblastoma
    Bujung Hong
    Manolis Polemikos
    Hans E. Heissler
    Christian Hartmann
    Makoto Nakamura
    Joachim K. Krauss
    Fluids and Barriers of the CNS, 15
  • [22] Challenges in cerebrospinal fluid shunting in patients with glioblastoma
    Hong, Bujung
    Polemikos, Manolis
    Heissler, Hans E.
    Hartmann, Christian
    Nakamura, Makoto
    Krauss, Joachim K.
    FLUIDS AND BARRIERS OF THE CNS, 2018, 15
  • [23] A Plasma microRNA Signature As a Biomarker for Acquired Aplastic Anemia
    Hosokawa, Kohei
    Kajigaya, Sachiko
    Feng, Xingmin
    Desierto, Marie J.
    Ibanez, Maria del Pilar Fernandez
    Rios, Olga
    Weinstein, Barbara
    Scheinberg, Phillip
    Townsley, Danielle M.
    Young, Neal S.
    BLOOD, 2016, 128 (22)
  • [24] A plasma microRNA signature as a biomarker for acquired aplastic anemia
    Hosokawa, Kohei
    Kajigaya, Sachiko
    Feng, Xingmin
    Desierto, Marie J.
    Ibanez, Maria del Pilar Fernandez
    Weinstein, Olga Rios Barbara
    Scheinberg, Phillip
    Townsley, Danielle M.
    Young, Neal S.
    HAEMATOLOGICA, 2017, 102 (01) : 69 - 78
  • [25] Circulating microRNA signature as novel biomarker for osteoarthritis development
    Ntoumou, E.
    Braoudaki, M.
    Lambrou, G.
    Stefanou, N.
    Papathanasiou, I.
    Poulou, M.
    Anastasopoulou, L.
    Malizos, K.
    Trachana, V.
    Tzetis, M.
    Tsezou, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 1001 - 1001
  • [26] In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid
    Gallego, Juan A.
    Gordon, Marc L.
    Claycomb, Kierstyn
    Bhatt, Mahima
    Lencz, Todd
    Malhotra, Anil K.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 47 (02) : 243 - 248
  • [27] MicroRNA Dysregulation in Cerebrospinal Fluid in Patients with Schizophrenia
    Gallego, Juan A.
    Lencz, Todd
    Cantley, Brian
    Malhotra, Anil
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S235 - S236
  • [28] In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid
    Juan A. Gallego
    Marc L. Gordon
    Kierstyn Claycomb
    Mahima Bhatt
    Todd Lencz
    Anil K. Malhotra
    Journal of Molecular Neuroscience, 2012, 47 : 243 - 248
  • [29] Biomarker discovery in cerebrospinal fluid of depressed patients
    Ditzen, C.
    Tang, N.
    Jacob, A.
    Uhr, M.
    Miller, C.
    Turck, C. W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S19 - S20
  • [30] Cystatin C in cerebrospinal fluid as a biomarker of ALS
    Tsuji-Akimoto, Sachiko
    Yabe, Ichiro
    Niino, Masaaki
    Kikuchi, Seiji
    Sasaki, Hidenao
    NEUROSCIENCE LETTERS, 2009, 452 (01) : 52 - 55